PHARMACOSCOPY: Breaking resistance of refractory blood cancers through ex vivo automated image-based analysis of drug action
Dauer: 46 Monate, Fördersumme: € 904.000
Systems precision medicine of inborn errors of the immune system (PrecisePID)
Dauer: 48 Monate, Fördersumme: € 923.200